PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

News

Pharma deals at 41st JP Morgan Healthcare conference

Against a backdrop of challenging circumstances around the globe in 2022, what do the pharma deals announced during the recent [...]

1 Feb 2023
Read full article

MHRA ramps up assessment capacity for in-vitro diagnostic devices

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended the designation of UL International UK Ltd as an [...]

30 Jan 2023
Read full article

JP Morgan Healthcare conference research trends in 2023

PMC reviews insights from the 41st JP Morgan Healthcare conference, focusing on some of the new treatments and technologies to [...]

25 Jan 2023
Read full article

EC adopts proposal to allow more time to certify medical devices

Fears of a shortage of medical devices have led the European Commission (EC) to adopt a proposal to extend the [...]

23 Jan 2023
Read full article

ICH webinar to update on M11 clinical trial guideline

A free webinar on the M11 Guideline has been organised by the International Council for Harmonisation (ICH) M11 Expert Working [...]

17 Jan 2023
Read full article

BIA reassured by Chancellor on life science support

The UK BioIndustry Association (BIA) appears to have won a reprieve on proposed cuts to SME R&D tax credits, via [...]

12 Jan 2023
Read full article

EMA reminder that clinical trials must use CTIS

The European Medicines Agency (EMA) has issued a reminder that from 31 January 2023 clinical trial sponsors must use the [...]

9 Jan 2023
Read full article

OHE Innovation Policy Prize

The Office of Health Economics (OHE) launched a biennial competition in early 2022 to answer the question ‘How can policymakers [...]

5 Jan 2023
Read full article

EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies

The European Medicines Agency (EMA) and European Centre for Disease Prevention and Control (ECDC) held the first meeting of the [...]

30 Dec 2022
Read full article

UK government commits over £175 million to genomics research

On 13 December 2022 the UK government announced a programme of funding for genomic research, including £105 million for diagnosis [...]

27 Dec 2022
Read full article

Amgen strengthens rare disease drug portfolio with purchase of Horizon

A deal valued at $27.8 billion has been struck between Amgen and Horizon Therapeutics, wherein Amgen will buy the orphan [...]

22 Dec 2022
Read full article

ABPI asks UK government to review VPAS as clawback will hit 26.5% of sales revenue in 2023

In 2023 manufacturers of branded medicines will be required to return almost £3.3bn in sales revenue to the government under [...]

20 Dec 2022
Read full article

Medical affairs outsourcing trends and benefits

What is the outlook for medical affairs up to 2030, and what are the advantages for pharma and biotechs from [...]

19 Dec 2022
Read full article

UK MHRA updates how to report medical device vigilance

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has updated the way to report adverse incidents involving medical devices. [...]

14 Dec 2022
Read full article

European Council backs delay to Medical Devices Regulation (MDR) deadlines

The Regulatory Affairs Professionals Society (RAPS) reports that the European Council supports a proposal made by the European Commission to [...]

12 Dec 2022
Read full article

Categories

  • Awards
  • Consultants
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #ClinicalTrials #DCVMN #diagnostics #drugdevelopment #drugpricing #EC #EMA #EU #FDA #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #mentalhealth #mhra #NICE #outsourcing #PatientAccess #pharmaregulation #pharmatrends #projectorbis #quality #rarediseases #regulation #regulatory #ukpharma AI Biotech Capabilities Brochure Clinical Research Clinical Resourcing COVID-19 CRO DITTurkey Drug Price Healthcare Medical Affairs medicaldevices Patient Care Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital